The good news is that a recent study of Pfizer’s antiviral drug Paxlovid found that taking the pill within 3 days of symptoms cut the risk of hospitalization by 89% for the most high-risk patients.
That drug could get FDA approval by the end of the month https://t.co/akj6UwcWsJ